<HTML><HEAD><META http-equiv="Content-type" content="text/html;charset=UTF-8"></HEAD><BODY><DIV><P><BR>               <BR>               <BR>               <BR>                  1     INDICATIONS AND USAGE<BR>               <BR>               <BR>               <BR>                  <BR>                     <BR>                        ARCAPTA NEOHALER is a long-acting beta2-adrenergic agonist indicated for: <BR>                        The long term, once-daily maintenance bronchodilator treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema. (1.1) <BR>                        Important limitations:<BR>                        <BR>                           ARCAPTA NEOHALER is NOT indicated to treat acute deteriorations of chronic obstructive pulmonary disease. (1.2)<BR><BR>                           <BR>                           ARCAPTA NEOHALER is NOT indicated for asthma. (1.2)<BR>                        <BR>                     <BR>                  <BR>               <BR>               <BR>                  <BR>                     <BR>                     <BR>                     1.1     Maintenance Treatment of COPD<BR>                     <BR>                        ARCAPTA NEOHALER is a long-acting beta2-agonist indicated for long-term, once-daily maintenance bronchodilator treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema. <BR>                     <BR>                     <BR>                  <BR>               <BR>               <BR>                  <BR>                     <BR>                     <BR>                     1.2     Important Limitations of Use<BR>                     <BR>                        ARCAPTA NEOHALER is not indicated to treat acute deteriorations of chronic obstructive pulmonary disease [see W<BR>                           arnings and Precautions<BR>                            (5.2)].<BR>                        ARCAPTA NEOHALER is not indicated to treat asthma. The safety and effectiveness of ARCAPTA NEOHALER in asthma have not been established.<BR>                     <BR>                     <BR>                  <BR>               <BR>            <BR>         </P></DIV></HTML>